| Q83336232 | A Classification Approach for Risk Prognosis of Patients on Mechanical Ventricular Assistance |
| Q34556967 | Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. |
| Q38249997 | Biomarkers in mechanical circulatory support |
| Q47101038 | Experience with the SynCardia total artificial heart in a Canadian centre. |
| Q47696043 | Long-term clinical results of acute myocardial infarction at the left main trunk requiring percutaneous cardiopulmonary support |
| Q43545249 | Lower body surface area is highly related to mortality due to stroke or systemic bleeding in patients receiving an axial flow blood pump as a left ventricular assist device |
| Q38667394 | Postoperative Management for Patients With Durable Mechanical Circulatory Support Devices |
| Q41029983 | Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients |
| Q33818507 | Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation |
| Q47577914 | Reviewing the use of ventricular assist devices in the elderly: where do we stand today? |
| Q30487874 | Serum Brain Natriuretic Peptide Concentration 60 Days after Surgery as a Predictor of Long-term Prognosis in Patients Implanted with a Left Ventricular Assist Device |
| Q38216313 | Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival |
| Q37810454 | Surgical approach to end-stage heart failure |
| Q33568255 | Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients |
| Q33951313 | Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study |
| Q88188468 | [Noncardiological surgical procedure for patients implanted with a ventricular assist device. Anesthesiological management concepts] |